Plus, news about Merus, Supernus and Verrica:
Syndax Pharmaceuticals’ $350M deal with Royalty Pharma: The agreement is based on US sales …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
With a new $132 million in hand, Alterome Therapeutics is finally divulging what it’s working on. The oncology company will be using its Series B
Children younger than age 5 years with HIV who received antiretroviral treatment (ART) died globally at percentages two to nine times higher than older children,
Rise and shine, everyone, another busy day is on the way. Sadly, gray skies are hovering over the Pharmalot campus again, but our spirits remain